Seminars in arthritis and rheumatism
Journal
Overview
publication venue for
-
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria..
74.
2025
-
Progress in APS pregnancy: Results from the IMPACT trial..
72S.
2025
-
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitations..
70.
2024
-
Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group..
71.
2024
-
Characterizing molecular targets in difficult-to-treat rheumatoid arthritis..
70S.
2024
-
The cause is worse than the effect: Inequities in the United States health system; how could we change them?.
70S.
2024
-
Highlights from the 2024 Rheumatoid Arthritis Research Summit..
70S.
2024
-
New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry..
70.
2024
-
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study..
67.
2024
-
Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry"..
66.
2024
-
Reliability assessment of the OMERACT whole-body magnetic resonance imaging scoring system for juvenile idiopathic arthritis..
66.
2024
-
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows..
65.
2024
-
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation..
65.
2024
-
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")..
65.
2023
-
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group..
64.
2023
-
Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the "CAPS Registry"..
63.
2023
-
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease..
57.
2022
-
Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database..
57.
2022
-
Monosodium urate deposition in the lumbosacral spine of patients with gout compared with non-gout controls: A dual-energy CT study..
56.
2022
-
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set..
51.
2021
-
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial..
51.
2021
-
Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study..
51.
2021
-
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis..
51.
2021
-
Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis..
50.
2020
-
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists..
50.
2020
-
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis..
50.
2020
-
Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients..
49.
2019
-
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort..
49.
2019
-
Racial/Ethnic variations in morbidity and mortality in Adult Onset Still's Disease: An analysis of national dataset..
49.
2019
-
A better look at rheumatoid arthritis: Using imaging to improve patient outcomes..
48.
2018
-
A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women..
48.
2018
-
Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus..
48.
2018
-
Arterial lesions in giant cell arteritis: A longitudinal study..
48.
2018
-
Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study..
47.
2017
-
Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies..
47.
2017
-
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study..
47.
2017
-
Pilot study of a multidisciplinary gout patient education and monitoring program..
46.
2016
-
Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects..
46.
2016
-
Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years..
46.
2016
-
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry..
45.
2015
-
Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients..
43.
2013
-
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries..
40.
2010
-
A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial)..
39.
2009
-
Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis..
33.
2004
-
Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate..
23.
1994
-
The effects of diclofenac sodium on arachidonic acid metabolism..
15.
1985
-
Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study"..
46.
2016
-
Cervical spine involvement early in the course of rheumatoid arthritis..
43.
2013
-
Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review..
42.
2012
-
Anakinra's efficacy is variable in refractory gout: report of ten cases..
40.
2010
-
The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon..
33.
2004
-
Calcitonin in the treatment of transient osteoporosis of the hip..
32.
2003
-
Sternoclavicular infectious arthritis in previously healthy adults..
32.
2002
-
Leukotriene antagonists and the Churg-Strauss syndrome..
31.
2002
-
Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment..
26.
1997
-
Human immunodeficiency virus-associated atypical mycobacterial skeletal infections..
25.
1996
-
Laryngeal involvement in systemic lupus erythematosus..
22.
1992
-
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group.
2025
-
Transformative approaches for effective clinical trials to reduce the disease burden of osteoarthritis.
2025
-
Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
2023
-
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
2022
-
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group.
2021
-
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group.
2021
-
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.
2020
-
The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group.
2020
-
Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid.
2015
-
Rheumatoid arthritis: Perioperative management of biologics and DMARDs.
2015
-
Proceedings of the 2013 Rheumatology Winter Clinical Symposia.
2013
-
The broad spectrum of urate crystal deposition: unusual presentations of gouty tophi.
2012
-
Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis.
2006
-
Antiphospholipid antibody syndrome: immunologic and clinical aspects.
1990
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)